Farther Finance Advisors LLC boosted its holdings in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 41.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,157 shares of the company’s stock after acquiring an additional 634 shares during the quarter. Farther Finance Advisors LLC’s holdings in Elevance Health were worth $796,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Raelipskie Partnership acquired a new stake in shares of Elevance Health during the 3rd quarter worth about $26,000. Dunhill Financial LLC boosted its stake in Elevance Health by 57.8% during the third quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock worth $37,000 after buying an additional 26 shares during the period. OFI Invest Asset Management acquired a new stake in shares of Elevance Health during the fourth quarter valued at about $29,000. Peterson Financial Group Inc. purchased a new stake in shares of Elevance Health in the 3rd quarter valued at approximately $44,000. Finally, Crews Bank & Trust acquired a new position in shares of Elevance Health in the 4th quarter worth approximately $34,000. Hedge funds and other institutional investors own 89.24% of the company’s stock.
Insider Activity at Elevance Health
In other news, CAO Ronald W. Penczek sold 443 shares of Elevance Health stock in a transaction on Monday, March 10th. The shares were sold at an average price of $415.13, for a total value of $183,902.59. Following the transaction, the chief accounting officer now directly owns 1,847 shares of the company’s stock, valued at $766,745.11. The trade was a 19.34 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Charles Morgan Kendrick, Jr. sold 3,504 shares of the stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $396.30, for a total transaction of $1,388,635.20. Following the sale, the executive vice president now owns 10,116 shares of the company’s stock, valued at approximately $4,008,970.80. This represents a 25.73 % decrease in their position. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Report on Elevance Health
Elevance Health Stock Up 1.1 %
Shares of NYSE ELV opened at $421.72 on Friday. The business has a 50-day moving average of $395.45 and a two-hundred day moving average of $429.65. The company has a market capitalization of $95.88 billion, a price-to-earnings ratio of 16.47, a price-to-earnings-growth ratio of 1.18 and a beta of 0.86. Elevance Health, Inc. has a 1 year low of $362.21 and a 1 year high of $567.26. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.45 and a quick ratio of 1.50.
Elevance Health (NYSE:ELV – Get Free Report) last announced its quarterly earnings results on Thursday, January 23rd. The company reported $3.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a return on equity of 18.28% and a net margin of 3.38%. On average, analysts forecast that Elevance Health, Inc. will post 33.96 earnings per share for the current fiscal year.
Elevance Health Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Investors of record on Monday, March 10th will be paid a dividend of $1.71 per share. This is a positive change from Elevance Health’s previous quarterly dividend of $1.63. This represents a $6.84 annualized dividend and a yield of 1.62%. The ex-dividend date is Monday, March 10th. Elevance Health’s dividend payout ratio (DPR) is currently 26.71%.
Elevance Health Company Profile
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Featured Stories
- Five stocks we like better than Elevance Health
- Top Biotech Stocks: Exploring Innovation Opportunities
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- What Makes a Stock a Good Dividend Stock?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV – Free Report).
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.